Analysis published 17 May 2026

AI-generated · cited to primary sources · not investment advice

IIFL Finance (532636) Jan 2026 Filing Analysis

01 · Management Credibility

Does management do what it says?

ExceededCredit Cost
100/100

The company significantly outperformed its provision guidance for the full year and the second half. Consolidated loan losses and provisions for FY26 stood at ₹1,738.2 Cr on a total income of ₹7,626.4 Cr, with Q4FY26 provisions dropping 19% QoQ. (1 exceeded across 1 tracked commitment)

Next year we will try to bring it to less than 2%. So, we are on track for that.

IIFL Finance · Concall Transcript · Jan 2026 · p.8
ExceededOther Findings
83/100

The company has reached a phygital reach of approximately 4,800 branches, indicating active expansion. (1 in progress, 3 met, 1 exceeded across 5 tracked commitments)

This is supposed to get over in 60 days' time.

IIFL Finance · Concall Transcript · Jan 2026 · p.6
Capital Adequacy Ratio CRAR

Management intends to maintain leverage around 4-4.5x and target a capital adequacy ratio closer to 20%. — target: Leverage 4-4.5x, CRAR ~20%

Our leverage, we will keep it around 4-4.5, and capital adequacy, we would like it to be closer to 20.

IIFL Finance · Concall Transcript · Jan 2026 · p.7

See the full cited Management analysis of IIFL Finance

Create free account →
04 · Risk

What could break the thesis?

IBC and SARFAESI Recovery Outcomes

This risk is largely resolved as the company executed a one-time cleanup by selling the discontinued Micro LAP and BLC portfolios (totaling ~INR 875-900 crore) to an Asset Reconstruction Company (ARC). (1 resolved)

Girish took a view which board has agreed with him that we should basically dispose of that portfolio once to ARC... almost INR 875 crore of total portfolio deal has happened. And that cleans the entire thing.

IIFL Finance · Concall Transcript · Jan 2026 · p.10

See the full cited Risk analysis of IIFL Finance

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.